Nuvalent Inc [NUVL] stock is trading at $90.42, up 0.87%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The NUVL shares have gain 2.75% over the last week, with a monthly amount glided 14.98%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on October 15, 2025, and set its price target to $135. Raymond James started tracking the stock assigning a Outperform rating and suggested a price target of $105 on September 03, 2025. Piper Sandler initiated its recommendation with a Overweight and recommended $112 as its price target on August 19, 2025. UBS upgraded its rating to Buy for this stock on March 14, 2025, but kept the price target unchanged to $100. In a note dated December 30, 2024, H.C. Wainwright initiated a Buy rating and provided a target price of $110 on this stock.
Nuvalent Inc [NUVL] stock has fluctuated between $55.53 and $105.13 over the past year. Currently, Wall Street analysts expect the stock to reach $123 within the next 12 months. Nuvalent Inc [NASDAQ: NUVL] shares were valued at $90.42 at the most recent close of the market. An investor can expect a potential return of 36.03% based on the average NUVL price forecast.
Analyzing the NUVL fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.33, Equity is -0.33 and Total Capital is -0.37.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 88.74 points at the first support level, and at 87.05 for the second support level. However, for the 1st resistance point, the stock is sitting at 92.50, and for the 2nd resistance point, it is at 94.57.
Ratios To Look Out For
For context, Nuvalent Inc’s Current Ratio is 13.57. Also, the Quick Ratio is 13.57, while the Cash Ratio stands at 1.7.
Transactions by insiders
Recent insider trading involved James Richard Porter, Officer, that happened on Oct 16 ’25 when 27000.0 shares were purchased. Officer, DEBORAH MILLER completed a deal on Oct 15 ’25 to buy 54000.0 shares. Meanwhile, Chief Financial Officer Balcom Alexandra sold 20000.0 shares on Oct 13 ’25.
